GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Bill Weldon, Johnson & Johnson CEO, Resigns

February 21, 2012 | About:
The Science of Hitting

The Science of Hitting

231 followers
Johnson & Johnson issued a press release on Tuesday stating the following:

William Weldon, current Chairman and CEO, will relinquish the CEO position on April 26th; he will remain Chairman of the Board.

Alex Gorsky (age 51), currently the Vice Chairman of the Company's Executive Committee with responsibility for the Medical Devices and Diagnostics Group, will take over as CEO on that same day. He will become the seventh CEO in the company’s history, dating back to 1886; he will be nominated to the Board at the 2012 Shareholder Meeting.

"Alex is an experienced, visionary and disciplined leader," Mr. Weldon said. "I look forward to the transition of leadership and to a bright future for Johnson & Johnson."

The news comes after years of struggles at JNJ due to product recalls. Mr. Weldon was named CEO and Chairman in January of 2002; during his tenure as chief executive, the stock price increased by just 14%, largely due to the valuation in the early 2000's. Over that same period, EPS increased by roughly 9% per annum.

LINK TO SEC FILING

About the author:

The Science of Hitting
I'm a value investor, with a focus on patience; I look to buy great companies that are suffering from short term issues, and hope to load up when these opportunities present themselves. As this would suggest, I run a fairly concentrated portfolio by most standards, usually with 8-10 names; from the perspective of a businessman rather than a market participant / stock trader, I believe this is more than sufficient diversification.

I hope to own a collection of great businesses; to ever sell one, I would demand a substantial premium to the average market valuation due to what I believe are the understated benefits to the long term investor of superior fundamentals and time on intrinsic value. I don't have a target when I purchase a stock; my goal is to replicate the underlying returns of the business in question - which if I've done my job properly, should be very attractive over many years.

Rating: 4.1/5 (15 votes)

Comments

kfh227
Kfh227 premium member - 2 years ago
JNJ was overvalued in 2002. The only reason for the bad performance was this simple fact.
The Science of Hitting
The Science of Hitting premium member - 2 years ago
Assuming you meant 2002? Added a note to allude to that fact; thanks Kfh227
kfh227
Kfh227 premium member - 2 years ago
Yes, meant 2002. Fixed it ;-)

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide